Search results
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 6 hours agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 2 hours agoPharma giant Pfizer Inc. (NYSE: PFE) announced on Wednesday after markets closed that its gene...
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 hours agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 9 hours agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Pfizer's gene-therapy trial failure boosts Sarepta's stock
Morningstar· 4 hours agoShares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial. Pfizer Inc. said ...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 1 day agoSome say the art of investing is the ability of catching falling knives. Pfizer Inc. (NYSE:PFE) shares have sold off in 2023 and represent an attractive...
Sarepta Therapeutics gains as Pfizer failure removes overhang
Investing.com· 12 hours agoSarepta Therapeutics gains as Pfizer failure removes overhang
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 19 hours agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via Yahoo News· 20 hours agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Redditors Are Buying These 8 Dividend Stocks For Early Retirement
Benzinga via Yahoo Finance· 1 hour agoYoung Americans have always been allured by the idea of leaving their 9-to-5 grind and enjoying the...